Skip to main content

Advertisement

Log in

DNA NANOSTRUCTURES

Nanodevices for cancer vaccination

  • News & Views
  • Published:

From Nature Materials

View current issue Submit your manuscript

An elaborate DNA origami tubular nanodevice encapsulating antigens and adjuvants protects mice from cancer through tumour-specific immunomodulation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1: Subcutaneous administration of a tubular DNA origami nanodevice vaccine for robust antigen-specific immune response against tumours.

References

  1. Hollingsworth, R. E. & Jansen, K. NPJ Vaccines 4, 7 (2019).

    Article  Google Scholar 

  2. Van der Burg, S. H. et al. Nat. Rev. Cancer 16, 219–233 (2016).

    Article  Google Scholar 

  3. Smith, C. C. et al. Nat. Rev. Cancer 19, 465–478 (2019).

    Article  CAS  Google Scholar 

  4. Anguille, S. et al. Leukemia 26, 2186–2196 (2012).

    Article  CAS  Google Scholar 

  5. Kranz, L. M. et al. Nature 534, 396–401 (2016).

    Article  Google Scholar 

  6. Liu, S. et al. Nat. Mater. https://doi.org/10.1038/s41563-020-0793-6 (2020).

  7. Jiang, Q. et al. Adv. Mater. 31, e1804785 (2019).

    Article  Google Scholar 

  8. Wang, P. F. et al. Chem 2, 359–382 (2017).

    Article  CAS  Google Scholar 

  9. Lu, Y., Aimetti, A. A., Langer, R. & Gu, Z. Nat. Rev. Mater. 1, 16075 (2016).

    Article  Google Scholar 

  10. Ott, P. A. et al. Nature 547, 217–221 (2017).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zhen Gu.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, H., Gu, Z. Nanodevices for cancer vaccination. Nat. Mater. 20, 286–287 (2021). https://doi.org/10.1038/s41563-021-00941-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41563-021-00941-4

  • Springer Nature Limited

Navigation